University Of Miami
Social determinants linked to inferior survival outcomes for patients with mesothelioma
Social determinants of health and lack of access to specialty cancer care led to survival disparities among patients with malignant pleural mesothelioma, results of a retrospective study showed.
AI algorithm identifies potential therapeutic targets for glioblastoma
An artificial intelligence algorithm that uses computational analysis to identify possible therapeutic targets for glioblastoma multiforme and other types of cancer could have broad treatment implications, according to its developers.
FDA advisory panel backs polatuzumab vedotin-piiq benefit-risk profile in first-line DLBCL
Polatuzumab vedotin-piiq exhibited a favorable risk-benefit profile as first-line treatment for patients with large B-cell lymphoma, according to an 11-2 vote of the FDA’s Oncologic Drugs Advisory Committee.
World Cancer Day: Oncology leaders share practical advice to ‘close the care gap’
World Cancer Day will be observed Feb. 4.
ASH recognizes Choosing Wisely, Guideline Implementation champions
ASH recognized three Choosing Wisely champions and three guideline implementation champions at this year’s ASH Annual Meeting and Exposition.
Restrictive diet an 'unnecessary burden' for patients undergoing HSCT
NEW ORLEANS — Adults undergoing stem cell transplant who received a nonrestrictive diet had similar rates of infection, feeding outcomes and acute graft-versus-host disease as those on a low-microbial protective diet, according to a study.
Data support less aggressive approach before transplant in relapsed/refractory AML
NEW ORLEANS — Skipping intensive remission-induction chemotherapy prior to allogeneic hematopoietic stem cell transplant did not impact survival outcomes among patients with relapsed/refractory acute myeloid leukemia, according to a study.
Eligibility criteria more likely to exclude minorities from lymphoma clinical trials
Up to one-quarter of those seeking clinical trial enrollment for novel front-line therapies to treat diffuse large B-cell lymphoma are excluded based on organ function laboratory values, study results showed.
Risk for major adverse CV events increases for transgender women after orchiectomy
ANAHEIM, Calif. — Transgender women who undergo a gender-affirming orchiectomy may have an increased risk for major adverse cardiovascular events post-procedure, according to a speaker.
Neurosurgeon to lead brain cancer clinical trials at University of Miami
Ashish Shah, MD, has been named director of clinical trials and translational research at Sylvester Comprehensive Cancer Center’s Brain Tumor Initiative at University of Miami Miller School of Medicine.